Europe, Middle East & Africa
The IQVIA Institute for Human Data Science
Advancing Human Data Science
The IQVIA Institute for Human Data Science delivers objective, relevant insights and research that accelerates our understanding of how health systems function, how treatment is evolving, and how care is being delivered. These insights are critical to sound decision making, and ultimately to improved human health outcomes.
With access to IQVIA's institutional knowledge, advanced analytics, technology and unparalelled data, the Institute works in tandem with a broad set of stakeholders, including government agencies, academic institutions, the life sciences industry, and payers.
An Introduction to the IQVIA Institute and Algorithmic Art
The IQVIA Institute leverages collaborative academic relationships in the public and private sectors to provide market clarity in advancing human science globally through fact based healthcare discussions.
Find where Murray Aitken and Michael Kleinrock will be speaking next.
See press releases and news coverage about the IQVIA Institute.
Global Oncology Trends 2019
This report examines the productivity and output of the oncology pipeline, new treatment mechanisms, and which patients will likely benefit from new therapies. Our research brings into focus the amount spent on oncology medicines globally, clinical trial activity, complexity and success, and the outlook through 2023. The report also addresses shifts in therapy use with the emergence of immuno-therapies, Next-Generation Biotherapeutics and biosimilars.
Murray Aitken is a senior vice president at IQVIA and the executive director of the IQVIA Institute for Human Data Science.
Michael Kleinrock serves as research director for the IQVIA Institute for Human Data Science.